Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.
| Author | |
|---|---|
| Abstract | :
Binge-eating disorder (BED) is a common psychiatric condition with adverse psychological and metabolic consequences. Lisdexamfetamine (LDX) is the only approved BED drug treatment. New drugs to treat BED are urgently needed. |
| Year of Publication | :
2021
|
| Journal | :
Journal of psychopharmacology (Oxford, England)
|
| Number of Pages | :
2698811211032475
|
| Date Published | :
2021
|
| ISSN Number | :
0269-8811
|
| URL | :
https://journals.sagepub.com/doi/10.1177/02698811211032475?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
|
| DOI | :
10.1177/02698811211032475
|
| Short Title | :
J Psychopharmacol
|
| Download citation |